SIREN : 341727014
OCTOPUS BIOSAFETY is a French company founded 39 years ago, specialized in the sector Programmation informatique. Based in AURAY (56400), this company of category PME shows in 2024 a revenue of 52 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 52 308 € | 229 348 € | 21 801 € | 66 817 € | 223 341 € | N/C | N/C | N/C |
| Net income | -659 106 € | -1 777 066 € | -802 728 € | -1 010 572 € | -831 977 € | -1 406 355 € | -2 883 275 € | -430 376 € |
| EBITDA | -805 407 € | -546 322 € | -491 504 € | -601 241 € | -926 105 € | -1 562 952 € | -1 622 593 € | N/C |
| Net margin | -1260.0% | -774.8% | -3682.1% | -1512.4% | -372.5% | N/C | N/C | N/C |
In 2024, OCTOPUS BIOSAFETY achieves revenue of 52 k€. Revenue is declining over the period 2020-2024 (CAGR: -30.4%). Significant drop of -77% vs 2023. After deducting consumption (350 k€), gross margin stands at -298 k€, i.e. a rate of -570%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -805 k€, representing -1539.7% of revenue. Warning negative scissor effect: despite revenue change (-77%), EBITDA varies by -47%, reducing margin by 1301.5 pts. This reflects costs rising faster than revenue. Negative EBITDA means operations do not cover current expenses: concerning situation. Net income is negative at -659 k€ (-1260.0% of revenue), which will impact equity.
52 308 €
-297 919 €
-805 407 €
-837 482 €
-659 106 €
-1395.6%
The debt ratio (= Financial debt / Equity x 100) stands at -83%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches -134%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
-83.364%
-134.018%
-1024.049%
-0.925
27.3%
In 2024, the debt ratio of OCTOPUS BIOSAFETY (-83.36) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
In 2024, the financial autonomy of OCTOPUS BIOSAFETY (-134.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2024, the repayment capacity of OCTOPUS BIOSAFETY (-0.93) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 50.68. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
50.683
-0.152
In 2024, the liquidity ratio of OCTOPUS BIOSAFETY (50.68) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
In 2024, the interest coverage of OCTOPUS BIOSAFETY (-0.1x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 399 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 355 days. The gap of 44 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Inventory turnover is 1950 days (= Average inventory / Cost of goods x 360). This high level ties up cash and potentially creates obsolescence risk. Overall, WCR represents 555 days of revenue, i.e. 81 k€ to permanently finance.
80 630 €
399 j
355 j
1950 j
555 j
Based on 120 transactions of similar company sales (all years), the value of OCTOPUS BIOSAFETY is estimated at 14 207 € (range 8 031€ - 34 746€). The price/revenue ratio is 0.27x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 120 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare OCTOPUS BIOSAFETY with other companies in the same sector:
Voir toutes les statistiques du secteur Programmation informatique
The revenue of OCTOPUS BIOSAFETY in 2024 is 52 k€.
OCTOPUS BIOSAFETY recorded a net loss in 2024.
The headquarters of OCTOPUS BIOSAFETY is located in AURAY (56400), in the department Morbihan.
The tax return of OCTOPUS BIOSAFETY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
OCTOPUS BIOSAFETY operates in the sector Programmation informatique (NAF code 62.01Z). See the 'Sector positioning' section above to compare the company with its competitors.